Clinical Significance of CD133 and Hypoxia Inducible Factor-1α Gene Expression in Rectal Cancer after Preoperative Chemoradiotherapy

Clinical Oncology

Volumn 23, Issue 5, 2011, Pages 323-332

  Saigusa, S ^a   Tanaka, K ^a   Toiyama, Y ^a   Yokoe, T ^a   Okugawa, Y ^a   Koike, Y ^a   Fujikawa, H ^a   Inoue, Y ^a   Miki, C ^a   Kusunoki, M ^a  

^a MIE UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

CD133; HIF 1 ; Preoperative chemoradiotherapy; Rectal cancer

Indexed keywords

CD133 ANTIGEN; FLUOROURACIL; HYPOXIA INDUCIBLE FACTOR 1ALPHA; TEGAFUR;

ADULT; AGED; ARTICLE; CANCER CELL; CANCER CELL CULTURE; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER RECURRENCE; CHEMORADIOTHERAPY; CONTINUOUS INFUSION; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE ASSOCIATION; DISEASE FREE SURVIVAL; FEMALE; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IRRADIATION; MAJOR CLINICAL STUDY; MALE; MICRODISSECTION; OVERALL SURVIVAL; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; RECTUM CANCER; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

AGED; ANTIGENS, CD; CELL LINE, TUMOR; COMBINED MODALITY THERAPY; GENE EXPRESSION; GLYCOPROTEINS; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASM, RESIDUAL; PEPTIDES; RECTAL NEOPLASMS; SURVIVAL RATE;

EID: 79955674615     PISSN: 09366555     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clon.2010.09.012     Document Type: Article

References (28)

1. Han Z.B., Ren H., Zhao H., et al. Hypoxia-inducible factor (HIF)-1 alpha directly enhances the transcriptional activity of stem cell factor (SCF) in response to hypoxia and epidermal growth factor (EGF). Carcinogenesis 2008, 29:1853-1861.
2. Sainson R.C., Harris A.L. Hypoxia-regulated differentiation: let's step it up a Notch. Trends Mol Med 2006, 12:141-143.
3. Keith B., Simon M.C. Hypoxia-inducible factors, stem cells, and cancer. Cell 2007, 129:465-472.
4. Moeller B.J., Cao Y., Li C.Y., Dewhirst M.W. Radiation activates HIF-1 to regulate vascular radiosensitivity in tumors: role of reoxygenation, free radicals, and stress granules. Cancer Cell 2004, 5:429-441.
5. Gustafsson M.V., Zheng X., Pereira T., et al. Hypoxia requires notch signaling to maintain the undifferentiated cell state. Dev Cell 2005, 9:617-628.
6. Rankin E.B., Giaccia A.J. The role of hypoxia-inducible factors in tumorigenesis. Cell Death Differ 2008, 15:678-685.
7. Covello K.L., Kehler J., Yu H., et al. HIF-2alpha regulates Oct-4: effects of hypoxia on stem cell function, embryonic development, and tumor growth. Genes Dev 2006, 20:557-570.
8. Mizokami K., Kakeji Y., Oda S., et al. Clinicopathologic significance of hypoxia-inducible factor 1alpha overexpression in gastric carcinomas. J Surg Oncol 2006, 94:149-154.
9. Schindl M., Schoppmann S.F., Samonigg H., et al. Overexpression of hypoxia-inducible factor 1alpha is associated with an unfavorable prognosis in lymph node-positive breast cancer. Clin Cancer Res 2002, 8:1831-1837.
10. Yoshimura H., Dhar D.K., Kohno H., et al. Prognostic impact of hypoxia-inducible factors 1alpha and 2alpha in colorectal cancer patients: correlation with tumor angiogenesis and cyclooxygenase-2 expression. Clin Cancer Res 2004, 10:8554-8560.
11. Vermeulen L., Sprick M.R., Kemper K., et al. Cancer stem cells-old concepts, new insights. Cell Death Differ 2008, 15:947-958.
12. Visvader J.E., Lindeman G.J. Cancer stem cells in solid tumours: accumulating evidence and unresolved questions. Nat Rev Cancer 2008, 8:755-768.
13. Ieta K., Tanaka F., Haraguchi N., et al. Biological and genetic characteristics of tumor-initiating cells in colon cancer. Ann Surg Oncol 2008, 15:638-648.
14. Boman B.M., Huang E. Human colon cancer stem cells: a new paradigm in gastrointestinal oncology. J Clin Oncol 2008, 26:2828-2838.
15. Rich J.N. Cancer stem cells in radiation resistance. Cancer Res 2007, 67:8980-8984.
16. Baumann M., Krause M., Hill R. Exploring the role of cancer stem cells in radioresistance. Nat Rev Cancer 2008, 8:545-554.
17. Bao S., Wu Q., McLendon R.E., et al. Glioma stem cells promote radioresistance by preferential activation of the DNA damage response. Nature 2006, 444:756-760.
18. Yasuda H., Tanaka K., Saigusa S., et al. Elevated CD133, but not VEGF or EGFR, as a predictive marker of distant recurrence after preoperative chemoradiotherapy in rectal cancer. Oncol Rep 2009, 22:709-717.
19. Saigusa S., Tanaka K., Toiyama Y., et al. Correlation of CD133, OCT4, and SOX2 in rectal cancer and their association with distant recurrence after chemoradiotherapy. Ann Surg Oncol 2009, 16:3488-3498.
20. Matsumoto K., Arao T., Tanaka K., et al. mTOR signal and hypoxia-inducible factor-1 alpha regulate CD133 expression in cancer cells. Cancer Res 2009, 69:7160-7164.
21. Yoshikawa R., Kusunoki M., Yanagi H., et al. Dual antitumor effects of 5-fluorouracil on the cell cycle in colorectal carcinoma cells: a novel target mechanism concept for pharmacokinetic modulating chemotherapy. Cancer Res 2001, 61:1029-1037.
22. Japanese Society for Cancer of the Colon and Rectum General rules for clinical and pathological studies on cancer of the colon, rectum and anus 2006, Kanehara & Co, Tokyo.
23. Bijwaard K.E., Aguilera N.S., Monczak Y., et al. Quantitative real-time reverse transcription-PCR assay for cyclin D1 expression: utility in the diagnosis of mantle cell lymphoma. Clin Chem 2001, 47:195-201.
24. Bosset J.F., Collette L., Calais G., et al. Chemotherapy with preoperative radiotherapy in rectal cancer. N Engl J Med 2006, 355:1114-1123.
25. Sauer R., Becker H., Hohenberger W., et al. Preoperative versus postoperative chemoradiotherapy for rectal cancer. N Engl J Med 2004, 351:1731-1740.
26. Guillem J.G., Chessin D.B., Cohen A.M., et al. Long-term oncologic outcome following preoperative combined modality therapy and total mesorectal excision of locally advanced rectal cancer. Ann Surg 2005, 241:829-836. discussion 836-838.
27. Harada H., Itasaka S., Zhu Y., et al. Treatment regimen determines whether an HIF-1 inhibitor enhances or inhibits the effect of radiation therapy. Br J Cancer 2009, 100:747-757.
28. Sahlgren C., Gustafsson M.V., Jin S., et al. Notch signaling mediates hypoxia-induced tumor cell migration and invasion. Proc Natl Acad Sci USA 2008, 105:6392-6397.